Product Information
PAROXETINE CR 37.5 MG TABLET is a generic product labeled by Apotex Corp., priced at $0.3997 per EA under NDC 60505131803. Its NADAC has been published 314 times since Aug 19, 2020.
FDA first approved this application on Feb 16, 1999. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the paroxetine hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
37.5 mg/1
Manufacturer
Apotex Corp.NDC
60505131803
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PAROXETINE HYDROCHLORIDE HEMIHYDRATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020936FDA Approved
2/16/1999
TE Code
AB
On Market Since
8/9/2019
Pharmacological Classes
Price Statistics
The NADAC for PAROXETINE CR 37.5 MG TABLET has been published 314 times since Aug 19, 2020, and over the history we have for it it has declined 76.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3997 per EA |
|---|---|
| All-time high | $1.7299 (Sep 16, 2020) |
| All-time low | $0.3671 (Nov 20, 2024) |
| 52-week high | $0.5530 |
| 52-week low | $0.3997 |
| Median price | $0.7028 |
| Average price | $0.8118 |
| Largest weekly change | +50.9% (Feb 22, 2023) |
| Weeks tracked | 314 |
| Tracking since | Aug 19, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PAROXETINE CR 37.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PAROXETINE CR 37.5 MG TABLET, manufactured by Apotex Corp., is $0.3997 per EA (NDC 60505131803), effective Aug 19, 2026.
How has the price of PAROXETINE CR 37.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PAROXETINE CR 37.5 MG TABLET has declined 76.9%. It has been tracked across 314 weekly CMS publications since Aug 19, 2020.
What are the highest and lowest recorded NADAC prices for PAROXETINE CR 37.5 MG TABLET?
Since Aug 19, 2020, the NADAC for PAROXETINE CR 37.5 MG TABLET has ranged from a low of $0.3671 (Nov 20, 2024) to a high of $1.7299 (Sep 16, 2020), with a median of $0.7028 per EA.
Are there cheaper alternatives to PAROXETINE CR 37.5 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PAROXETINE CR 37.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PAROXETINE CR 37.5 MG TABLET?
PAROXETINE CR 37.5 MG TABLET (NDC 60505131803) is labeled by Apotex Corp., and CMS classifies it as a generic product.